RCAMU
Rothschild & Co Asset Management US’s Heron Therapeutics HRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,379,846
| Closed | -$12.6M | – | 275 |
|
|
2021
Q4 | $12.6M | Buy |
1,379,846
+305,321
| +28% | +$2.79M | 0.15% | 153 |
|
|
2021
Q3 | $11.5M | Sell |
1,074,525
-39,268
| -4% | -$420K | 0.14% | 168 |
|
|
2021
Q2 | $17.3M | Buy |
1,113,793
+75,998
| +7% | +$1.18M | 0.21% | 139 |
|
|
2021
Q1 | $16.8M | Sell |
1,037,795
-314,959
| -23% | -$5.11M | 0.21% | 141 |
|
|
2020
Q4 | $28.6M | Sell |
1,352,754
-257,845
| -16% | -$5.46M | 0.37% | 83 |
|
|
2020
Q3 | $23.9M | Buy |
1,610,599
+1,102,196
| +217% | +$16.3M | 0.43% | 90 |
|
|
2020
Q2 | $7.48M | Buy |
508,403
+6,416
| +1% | +$94.4K | 0.11% | 238 |
|
|
2020
Q1 | $5.89M | Buy |
501,987
+462,236
| +1,163% | +$5.43M | 0.09% | 245 |
|
|
2019
Q4 | $934K | Sell |
39,751
-1,841
| -4% | -$43.3K | 0.01% | 321 |
|
|
2019
Q3 | $769K | Buy |
41,592
+3,805
| +10% | +$70.4K | 0.01% | 324 |
|
|
2019
Q2 | $702K | Buy |
37,787
+9,267
| +32% | +$172K | 0.01% | 330 |
|
|
2019
Q1 | $697K | Sell |
28,520
-24,602
| -46% | -$601K | 0.01% | 340 |
|
|
2018
Q4 | $1.38M | Sell |
53,122
-385
| -0.7% | -$9.99K | 0.02% | 339 |
|
|
2018
Q3 | $1.69M | Buy |
+53,507
| New | +$1.69M | 0.02% | 343 |
|